1. Accueil >
  2. All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen >
Nasdaq

All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen

26-01-2024

January 26, 2024 – Company announcement no. 1


Please see attachment.

Contact information

Investor Relations
Disa Tuominen
+45 6038 5826
dkditu@chr-hansen.com

Press Relations
Sanne Seyer-Hansen
+45 6038 6207
dksash@chr-hansen.com

Attachment